Highlights From the American College of Cardiology's 2026 Scientific Sessions

Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting. Related Content: PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC

Episode metadata supplied by the publisher feed · Published Apr 10, 2026

Embed this episode

Attribution link and audio player

Ready to play

Highlights From the American College of Cardiology's 2026 Scientific Sessions

0:00 20:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Medical News?

This episode is 20 minutes long.

When was this JAMA Medical News episode published?

This episode was published on April 10, 2026.

Can I download this JAMA Medical News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!